CSF2 and juvenile myelomonocytic leukemia: Another example includes granulocyte-macrophage colony-stimulating factor (GM-CSF)-based CAR T cells targeting CD116, GM-CSF receptor, for the curative treatment of juvenile myelomonocytic leukemia (JMML).